These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19238505)

  • 1. Excimer laser debulking for percutaneous coronary intervention in left main coronary artery disease.
    Topaz O; Polkampally PR; Mohanty PK; Rizk M; Bangs J; Bernardo NL
    Lasers Med Sci; 2009 Nov; 24(6):955-60. PubMed ID: 19238505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of excimer laser debulking for critical lesions unsuitable for standard renal angioplasty.
    Topaz O; Polkampally PR; Topaz A; Polkampally CR; Jara J; Rizk M; McDowell K; Feldman G
    Lasers Surg Med; 2009 Nov; 41(9):622-7. PubMed ID: 19816915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary revascularization in heart transplant recipients by excimer laser angioplasty.
    Topaz O; Janin Y; Bernardo N; Bailey NT; Mohanty PK
    Lasers Surg Med; 2000; 26(5):425-31. PubMed ID: 10861697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-stent restenosis: mid-term results of debulking using excimer laser and drug-eluting balloons: sustained benefit?
    van den Berg JC; Pedrotti M; Canevascini R; Chimchila Chevili S; Giovannacci L; Rosso R
    J Invasive Cardiol; 2014 Jul; 26(7):333-7. PubMed ID: 24993991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-stent crossover technique from distal unprotected left main coronary artery to the left circumflex artery.
    Naganuma T; Chieffo A; Basavarajaiah S; Takagi K; Costopoulos C; Latib A; Carlino M; Montorfano M; Bernelli C; Nakamura S; Colombo A
    Catheter Cardiovasc Interv; 2013 Nov; 82(5):757-64. PubMed ID: 23674385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-hospital and mid-term outcomes of stent implantation in patients with protected and unprotected left main coronary artery disease; King Chulalongkorn Memorial Hospital experiences.
    Cholteesupachai J; Udayachalerm W; Srimahachota S; Buddhari W; Chaipromprasit J; Songmuang SB; Suithichaiyakul T
    J Med Assoc Thai; 2009 Jun; 92(6):755-60. PubMed ID: 19530580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Elective stenting of "unprotected" left main coronary stenosis in patients without contraindication to bypass surgery].
    Hofmann R; Kerschner K; Grund M; Leisch F
    Z Kardiol; 1999 Oct; 88(10):788-94. PubMed ID: 10552181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outlook of drug-eluting stent implantation for unprotected left main disease: insights on long-term clinical predictors.
    Vecchio S; Chechi T; Vittori G; Biondi Zoccai GG; Lilli A; Spaziani G; Giuliani G; Falchetti E; Margheri M
    J Invasive Cardiol; 2007 Sep; 19(9):381-7. PubMed ID: 17827507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combined use of Drug-eluting balloon and Excimer laser for coronary artery Restenosis In-Stent Treatment: The DERIST study.
    Ambrosini V; Golino L; Niccoli G; Roberto M; Lisanti P; Ceravolo R; Bernardi G; Armigliato P; Gabrielli G; Chizzola G; De Paulis C; Crea F; Colombo A
    Cardiovasc Revasc Med; 2017; 18(3):165-168. PubMed ID: 28081977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and angiographic results of angioplasty with a paclitaxel-eluting stent for unprotected left main coronary artery disease (a study of 101 consecutive patients).
    Cherradi R; Ouldzein H; Zouaoui W; Elbaz M; Puel J; Carrié D
    Arch Cardiovasc Dis; 2008 Jan; 101(1):11-7. PubMed ID: 18391867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated disease of the ostium left anterior descending or circumflex artery: management using a left main stenting technique. Clinical outcome at 2 years.
    Cubeddu RJ; Wood FO; Saylors EK; Mann T
    J Invasive Cardiol; 2007 Nov; 19(11):457-61. PubMed ID: 17986719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excimer laser in management of underexpansion of a newly deployed coronary stent.
    Lam SC; Bertog S; Sievert H
    Catheter Cardiovasc Interv; 2014 Jan; 83(1):E64-8. PubMed ID: 23703809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technical feasibility, safety, and clinical outcome of stenting of unprotected left main coronary artery bifurcation narrowing.
    Park SJ; Lee CW; Kim YH; Lee JH; Hong MK; Kim JJ; Park SW
    Am J Cardiol; 2002 Aug; 90(4):374-8. PubMed ID: 12161225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and long term results of unprotected left main stenting using drug eluting stents.
    Tzifos V; Gatsis A; Gerasimou A; Chatzis D; Theodorakis G
    Cardiol J; 2011; 18(2):165-70. PubMed ID: 21432823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of interventional strategy for unprotected left main coronary artery percutaneous coronary intervention on long-term survival.
    Lehmann R; Ehrlich JR; De Rosa S; Spyridopoulos I; Laskowski R; Kremer J; Herrmann E; Zeiher AM; Schächinger V; Fichtlscherer S
    Can J Cardiol; 2012; 28(5):553-60. PubMed ID: 22554579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
    Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheolytic effects of left main mid-shaft/distal stenting: a computational flow dynamic analysis.
    Rigatelli G; Zuin M; Dell'Avvocata F; Nguyen T
    Ther Adv Cardiovasc Dis; 2018 Jun; 12(6):161-168. PubMed ID: 29589515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-life experience of a stent-less revascularization strategy using a combination of excimer laser and drug-coated balloon for patients with acute coronary syndrome.
    Harima A; Sairaku A; Inoue I; Nishioka K; Oka T; Nakama Y; Dai K; Ohi K; Hashimoto H; Kihara Y
    J Interv Cardiol; 2018 Jun; 31(3):284-292. PubMed ID: 29464846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of outcome of percutaneous excimer laser coronary angioplasty of saphenous vein bypass graft lesions. The Percutaneous Excimer Laser Coronary Angioplasty Registry.
    Bittl JA; Sanborn TA; Yardley DE; Tcheng JE; Isner JM; Chokshi SK; Strauss BH; Abela GS; Walter PD; Schmidhofer M
    Am J Cardiol; 1994 Jul; 74(2):144-8. PubMed ID: 8023778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.